GGrantIndex
Sort

130,381 grants matching hiv

A Solid-Phase, Long-Acting CCR5 Monoclonal Antibody for HIV Transmission

$959,550
Jonah B. Sacha · Oregon Health & Science University · R01 · FY2020 · AI

MECHANISMS OF LIPODYSTROPHY IN HIV INFECTED PATIENTS

$959,511
University Of Texas Sw Med Ctr/Dallas · R01 · FY2001 · DK

QUALITY ASSURANCE FOR HIV & HIV RELATED CONFIDENTIAL TESTING IN ZIMBABWE

$959,507
Sibongile Zimuto · Zimbabwe National Quality Assurance Prog · U2G · FY2009 · PS

Global HIV/AIDS Vaccine Enterprise

$959,345
National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI

Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes

$959,255
Jeffrey David Klausner · University Of Southern California · R01 · FY2023 · AI

Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes

$959,172
Pamela Kohler · University Of Washington · UH3 · FY2022 · HD

Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination

$959,144
James M Binley · San Diego Biomedical Research Institute · R01 · FY2020 · AI

Conserved Elements Therapeutic DNA Vaccine for HIV

$959,000
Deborah L. Fuller · University Of Washington · R01 · FY2013 · AI

Administrative Core

$958,996
Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2014 · AI

Elucidating the Regulation of HIV RNA Functions: Translation Genome Packaging

$958,753
Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Defining Mechanisms of HIV-1 Gag:RNA Interactions and Virus Assembly

$958,753
Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

The Development of a Web-based Data Retrieval System for HIV Therapy Guidance

$958,725
Christos J Petropoulos · Monogram Biosciences, Inc. · R44 · FY2009 · AI

Center for Prevention Implementation Methods for Drug Abuse & Sex Risk Behavior

$958,554
C. Hendricks Brown · Northwestern University At Chicago · P30 · FY2014 · DA

Epstein-Barr Virus Associated Disorders

$958,430
Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Development Of Vaccines For Genital Herpes Simplex Infection

$958,430
Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Influenza and Emerging Infectious Diseases

$958,408
Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease

$958,404
Sulggi Angela Lee · University Of California, San Francisco · R61 · FY2019 · DA

Core A: Protein Sciences

$958,363
Neil King · University Of Washington · P01 · FY2022 · AI

Immune Regulation In Toxoplasmosis And Other Opportunistic Infections

$958,350
Alan Sher · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Global HIV/AIDS Vaccine Enterprise

$958,333
National Institute Of Allergy And Infectious Diseases · Y01 · FY2017 · AI

Global HIV/AIDS Vaccine Enterprise

$958,333
National Institute Of Allergy And Infectious Diseases · Y01 · FY2018 · AI

Global HIV/AIDS Vaccine Enterprise

$958,333
Kevin Osborne · National Institute Of Allergy And Infectious Diseases · Y01 · FY2019 · AI

Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence

$958,259
Angela D Kashuba · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI

Immunopathogenesis of acute and early HIV infection

$958,225
New York University School Of Medicine · P01 · FY2004 · AI

Identifying vulnerabilities in the long-lived HIV reservoir to accelerate its decay

$958,175
Ann C Duerr · Fred Hutchinson Cancer Center · R01 · FY2025 · AI